CliffBio
small molecule

RALDESY

TRAZODONE HYDROCHLORIDE

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyKamat Pharmatech →View the full company profile on CliffBio

Drug detail

Brand nameRALDESY
Active ingredientTRAZODONE HYDROCHLORIDE
Strength10MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2024
Marketing statusRX

Listed patents

PatentExpiresType
8133893March 2029substance, product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

RALDESY patent cliff — loss of exclusivity March 2029 | CliffBio